Oriel STAT A MATRIX Welcomes New Vice President of Business Development for Medical Device and Life Sciences RA/QA Practice

EDISON, N.J., Nov. 21, 2013 /PRNewswire/ -- To further strengthen its successful medical device and life sciences RA/QA practice team, Oriel STAT A MATRIX announces the appointment of Pete Gonzalez as Vice President of Business Development, Medical Device and Life Sciences Practice.

In his new position, Mr. Gonzalez will share responsibility for the strategic leadership and management of domestic and international business development for Oriel STAT A MATRIX's life sciences quality and regulatory consulting, auditing, and training solutions.  He will focus on serving clients in the medical device, in vitro diagnostic device, pharmaceutical, combination device, and biotechnology industry sectors. 

"Pete brings a background uniquely suited to the complex needs of our clients. He has deep knowledge of management systems, the product approval process, and regulatory strategy. With the addition of Pete to our team, more customers will be able to benefit from our ability to successfully guide them through the global regulatory compliance process," affirms Oriel STAT A MATRIX CEO Alan Marash.

Commenting on his new role at Oriel STAT A MATRIX, Mr. Gonzalez added, "The medical device and life sciences industry is a dynamic and constantly changing regulatory environment. New quality, safety, and compliance requirements are introduced frequently, making it a challenge for manufacturers to enter and maintain a position in the global marketplace. I look forward to helping companies navigate these requirements and improve business performance, so they can continue to bring their life-changing products to market."

Mr. Gonzalez joins Oriel STAT A MATRIX from SGS North America, where he was Business Development Manager and Auditor for the company's healthcare and life sciences division.  He has over 30 years of experience in quality, regulatory affairs, clinical affairs, auditing, operations, and business development in the medical device, in vitro medical device, and biotechnology industries. He has worked extensively with Notified Bodies, European Competent Authorities, Health Canada, US FDA, and other global regulatory bodies in a wide variety of capacities. In addition to his most recent position at SGS, Mr. Gonzalez has worked with TUV SUD/America/Product Service, LRQA, TUV Rheinland, Gen-Probe, Smith & Nephew (DonJoy Orthopedics), Sulzer Medica (Calcitek), Regulatory Technology Services, and Provasis Therapeutics.

Mr. Gonzalez has a BA in business administration and an MBA in international business.  He also holds industry credentials and certifications in regulatory affairs, quality auditing, engineering and management, and clinical trials design and management.

About Oriel STAT A MATRIX

Since 1968, Oriel STAT A MATRIX has provided organizations with best-in-class performance improvement training and consulting –  including FDA-regulated services, implementation of ISO 9000, and continual improvement methods such as Lean Six Sigma –  that enhance financial results and customer satisfaction.  In 1978, US FDA chose Oriel STAT A MATRIX to help develop regulations and train their investigators. Since then, we've been the industry leader in assisting medical device, pharmaceutical, and biotechnology manufacturers at every step, from achieving compliance with FDA and international regulations to making processes more effective and efficient, thus improving business performance.

Oriel STAT A MATRIX has offices in more than 18 countries and a diversified customer base that spans the globe and represents every economic sector. For further information about Oriel STAT A MATRIX, please visit www.orielstat.com or call 732.548.0600.

SOURCE Oriel STAT A MATRIX